問卷

TPIDB > Principal Investigator

Principal Investigator


Chi Mei Hospital, Liouying

Division of Nephrology

更新時間:2025-08-20

杜奕德
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2024-09-30 - 2026-06-30

Phase II

Active
A Phase 2b dose-finding, randomized, placebo-controlled, double-blind study to evaluate efficacy and safety of BAY 3283142 on top of standard of care in reducing albuminuria in patients with chronic kidney disease
  • Condition/Disease

    chronic kidney disease

  • Test Drug

    tablets

Participate Sites
6Sites

Not yet recruiting5Sites

Recruiting1Sites